Multidrug and toxin extrusion protein 1 (MATE1) and MATE2-K are organic cation/H ؉ antiporters that have recently been identified and suggested to be responsible for the brush border secretory transport of many cationic drugs in renal tubules. We here report our finding that 4,6-diamidino-2-phenylindole (DAPI) can be used as a probe substrate for rapid assays of the functionality of the human MATEs, hMATE1, and hMATE2-K, by taking advantage of its fluorescent nature. The specific cellular uptakes of DAPI by cloned hMATE1 and hMATE2-K, which were assessed by fluorescence intensity, were found to be rapid and saturable with the Michaelis constants of 1.13 and 3.16 M, respectively, indicating that DAPI is a good substrate of both hMATEs. It was found that many organic cations inhibit the specific uptake of DAPI by hMATE1 and hMATE2-K, and the extents of inhibition are in good correlation with those of inhibition of the specific uptake of [ 3 H]cimetidine as a typical substrate, indicating comparable performances of both substrates as probes in identifying inhibitors. Thus, DAPI can be an alternative probe substrate that enables fluorometric rapid assays of the functionality of both hMATEs. It was also found that the other major renal organic cation transporters, human organic cation transporter 2 (hOCT2), hOCT3, human novel organic cation transporter 1 (hOCTN1), and hOCTN2, cannot transport DAPI, although hOCT1, which is mainly expressed in the liver, can. Therefore, the DAPI uptake assay can be a method specific to the hMATEs among organic cation transporters in the human kidney.
Multidrug and toxin extrusion protein 1 (MATE1) and MATE2-K are organic cation/H ϩ antiporters that have recently been identified and suggested to be responsible for the brush border secretory transport of many cationic drugs, such as cimetidine, tetraethylammonium (TEA), N-methylnicotinamide, and metformin in renal tubules Tsuda et al., 2007) . Two human MATEs, hMATE1 and hMATE2, were originally identified in 2005 by Otsuka et al. (2005) . Shortly afterward, two splice variants of hMATE2, hMATE2-K and hMATE2-B, were identified, and it has been suggested that, among the hMATE2 variants, hMATE2-K is expressed most abundantly and specifically in the kidney, whereas the other hMATE2 variants, hMATE2 and hMATE2-B, are expressed only minimally or negligibly throughout the body (Masuda et al., 2006) . It is notable that a recent study using Mate1(Ϫ/Ϫ) mice has successfully proved the role of MATE1 in renal drug secretion by demonstrating that knocking out Mate1 results in a decrease in the renal excretion of metformin, which is accompanied by an increase in the plasma concentration of the drug (Tsuda et al., 2009 ).
MATEs have also been shown to recognize some anionic, amphoteric, and neutral compounds as inhibitors and/or substrates (Ohta et al., 2006 (Ohta et al., , 2009 Tanihara et al., 2007) . They include estrone sulfate, fluoroquinolones, such as norfloxacin, and corticosterone. Characteristics of the recognition of inhibitors and substrates by MATE1 and MATE2-K are of interest but are complicated and difficult to delineate. It is important to perform extensive transport assays to identify inhibitors and substrates and thereby clarify recognition characteristics.
4Ј,6-Diamidino-2-phenylindole (DAPI) is a fluorescent dye widely used for nuclear staining (Fig. 1) . It emits blue fluorescence by excitation with ultraviolet light only after intercalation into DNA double strands. Because this cationic compound is practically impermeable through the plasma membrane of most live cells, it is typically used for staining nuclei of fixed and dead cells (Kapuscinski, 1995) .
We here report our finding that DAPI is a good substrate for both hMATE1 and hMATE2-K. Taking advantage of its fluorescent nature, we have used it as a probe substrate for rapid assays of the functionality of the hMATEs.
hOCT1, 5Ј-AGA ATT CAG CCA TCA TGC CCA CCG TG-3Ј; reverse primer containing an XbaI restriction site (underlined) for hOCT1, 5Ј-TTT CTA GAC TCT CAG GTG CCC GAG GGT-3Ј; forward primer containing a XhoI restriction site (underlined) for hOCT2, 5Ј-GCC TCG AGG TCG ACA GAT CTG ATT CCG C-3Ј; reverse primer containing an XbaI restriction site (underlined) for hOCT2, 5Ј-TGT CTA GAG TCA TGA CAG CAG CAA CGG TCT-3Ј; forward primer containing an EcoRI restriction site (underlined) for hOCT3, 5Ј-GAG AAT TCG ATG GGC GGC GGG CGC ACC A-3Ј; reverse primer containing a SalI restriction site (underlined) for hOCT3, 5Ј-TAG TCG ACG TCG GGG GCC TCA AAG GTG AGA G-3Ј; forward primer containing an EcoRI restriction site (underlined) for hOCTN1, 5Ј-AGA ATT CCA TGC GGG ACT ACG ACG AGG T-3Ј; reverse primer containing an XbaI restriction site (underlined) for hOCTN1, 5Ј-GTT CTA GAA TTT CTC CAC AGG GTC TT-3Ј; forward primer containing an EcoRI restriction site (underlined) for hOCTN2, 5Ј-AGG AAT TCT TGG GTC GCC TGC TGC-3Ј; and reverse primer containing an XbaI restriction site (underlined) for hOCTN2, 5Ј-TCC TCT AGA CAG TCT TTC CTC TTC-3Ј. The amplified cDNA products were subcloned into pME18 vector and then transferred into pCI-neo vector.
Cell Culture. Madin-Darby canine kidney (MDCK) II cells and human embryonic kidney (HEK) 293 cells were maintained at 37°C and 5% CO 2 in DMEM supplemented with 10% FBS, 100 U/ml penicillin, and 100 g/ml streptomycin.
Preparation of MDCKII Cells Stably Expressing hMATEs. MDCKII cells were transfected with the plasmid carrying the cDNA of hMATE1 or hMATE2-K by using Lipofectamine 2000 (Invitrogen) as a transfection reagent, according to the manufacturer's instructions, and cultured in DMEM supplemented with 10% FBS and 800 g/ml Geneticin for 2 to 3 weeks. Antibiotic-resistant clones were selected and tested for the transport of [ 3 H]cimetidine as a probe substrate.
Preparation of HEK293 Cells Transiently Expressing hMATEs, hOCTs, and hOCTNs. HEK293 cells (1.5 ϫ 10 5 cells/well initially) were grown on 24-well plates coated with poly-L-lysine for 12 h, transfected with 1 g/well of the plasmid carrying the cDNA of hMATE1, hMATE2-K, hOCT1, hOCT2, hOCT3, hOCTN1, or hOCTN2 by using 1 g/well of Lipofectamine 2000, and cultured for 24 h for transient expression. For fluorescent microscopic observation, pEGFP plasmid (0.1 g/well) was cotransfected.
Uptake Study in MDCKII Cells Stably Expressing hMATEs. For the assays of DAPI uptake, MDCKII cells stably expressing hMATE1 or hMATE2-K (0.5 ϫ 10 5 cells/well initially) were grown on 96-well plates for 72 h. In regular uptake assays, the cells in each well were preincubated in 0.25 ml of DAPI-free uptake buffer (130 mM KCl, 2 mM K 2 HPO 4 , 1.2 mM MgSO 4 , 1.0 mM CaCl 2 , 5 mM glucose, and 20 mM HEPES, pH 7.4) for 10 min. In uptake assays to examine the effect of intracellular acidification, we used a NH 4 Cl prepulse method (Boron and De Weer, 1976) , in which the cells were preincubated in the uptake buffer free of DAPI and supplemented with 20 mM NH 4 Cl (0.25 ml) for 10 min and thereafter in the uptake buffer free of DAPI and NH 4 Cl (0.25 ml) for 5 min. In uptake assays to examine the effect of extracellular pH, 20 mM HEPES was replaced with 20 mM MES for pH 6.0 and below. Uptake assays were started by replacing the DAPI-free uptake buffer for preincubation with buffer containing DAPI (0.1 ml). All of the procedures were conducted at 37°C. Assays were stopped by addition of ice-cold DAPI-free uptake buffer (0.25 ml), and the cells were washed two times with 0.25 ml of the same buffer. Then, each well was filled with 0.25 ml of ice-cold DAPI-free uptake buffer, and the intensity of fluorescence from DAPI was measured with a fluorescence plate reader, using the wavelengths of 360 nm for excitation and 460 nm for emission, for the evaluation of uptake.
For the assays of [ 3 H]cimetidine uptake, MDCKII cells stably expressing hMATE1 or hMATE2-K (1.5 ϫ 10 5 cells/well initially) were grown on 24-well plates for 72 h. Because cimetidine is transported by hMATEs by an H ϩ -coupled antiport mechanism, we used the NH 4 Cl prepulse method to generate an outward H ϩ gradient by intracellular acidification for the evaluation of transport by uptake measurements. The cells in each well were pretreated as described above, using 1 ml each of preincubation buffers, and uptake assays were started by replacing the cimetidine-free uptake buffer for preincubation with one containing [ 3 H]cimetidine (0.25 ml). All of the procedures were conducted at 37°C. Assays were stopped by addition of ice-cold cimetidine-free uptake buffer (2 ml), and the cells were washed two times with 2 ml of the same buffer. The cells were solubilized in 0.5 ml of 0.2 M NaOH dmd.aspetjournals.org solution containing 0.5% SDS at room temperature for 1 h, and the associated radioactivity was measured by liquid scintillation counting, using 3 ml of Clear-sol I (Nakarai Tesque, Kyoto, Japan) as a scintillation fluid, for the evaluation of uptake.
Cellular protein content was determined by the method of Lowry et al. (1951) using bovine serum albumin as the standard. Uptake assays were also conducted in mock cells, which were transfected with empty pCI-neo vector, to estimate nonspecific uptake.
Fluorescent Microscopy. HEK293 cells transiently expressing one of the cloned transporters and cultured on 24-well plates coated with poly-L-lysine were detached using 0.05% EDTA in phosphate-buffered saline (pH 7.4), seeded at a density of 0.5 ϫ 10 5 cells on a 35-mm glass-bottom dish coated with poly-L-lysine, and cultured overnight. After incubation of the cells in uptake buffer containing DAPI (0.5 M) at 37°C for 20 min, the fluorescent images of DAPI and GFP were directly visualized by using a confocal laser scanning microscope (LSM510; Carl Zeiss, Jena, Germany).
Uptake Study in HEK293 Cells Transiently Expressing hOCTs and hOCTNs. HEK293 cells transiently expressing each of the hOCTs and hOCTNs and cultured on the 24-well plates were used to assess the uptake of D-glucose) and supplemented with 20 mM HEPES (pH 8.5). The cells in each well were preincubated in substrate-free uptake buffer (1 ml) at 37°C for 10 min. Uptake assays were started by replacing the substrate-free uptake buffer for preincubation with one containing one of the radiolabeled substrates (0.25 ml) and, thereafter, conducted in the same manner as the assays of [ 3 H]cimetidine uptake.
Data Analysis. Specific uptake by the introduced transporter, hMATE1 or hMATE2-K, was estimated by subtracting the uptake in mock cells from that in the transporter-transfected cells.
Saturable transport of DAPI was analyzed by assuming Michaelis-Menten type carrier-mediated transport represented by the following equation:
The maximum transport rate (V max ) and the Michaelis constant (K m ) were estimated by fitting this equation to the experimental profile of the uptake rate (v) versus the substrate (DAPI) concentration (s), using a nonlinear least-squares regression analysis program, WinNonlin (Pharsight, Mountain View, CA), and the reciprocal of variance as the weight. The parameters are presented as the computer-fitted values with S.E.
Experimental data are presented as the means Ϯ S.E., and statistical analysis was performed using two-tailed, unpaired Student's t test or, when multiple comparisons were needed, analysis of variance followed by Dunnett's test, with p Ͻ 0.05 considered significant.
Results
Fluorescent Microscopic Observation of DAPI Uptake by hMATEs. The uptake of DAPI (0.5 M) was first examined by fluorescent microscopic observation in HEK293 cells transiently expressing hMATE1 and those expressing hMATE2-K. As shown in Fig. 2 , blue fluorescence from DAPI was observed in some cells in both preparations treated for transfection with hMATE1 and with hMATE2-K but not in mock cells. Furthermore, the fluorescence from DAPI was almost completely overlapped with green fluorescence from cotransfected GFP, which serves as a marker of successful transfection. These results indicate that DAPI was taken up into live cells expressing hMATE1 and those expressing hMATE2-K by these transporters.
Time Courses of DAPI Uptake by hMATEs. The uptake of DAPI (0.5 M) was greater in MDCKII cells stably expressing hMATE1 and those expressing hMATE2-K than in mock cells (Fig. 3) , consistent with the fluorescent microscopic observation (Fig. 2) and indicating its efficient uptake by both hMATEs. Because the uptakes increased in proportion to time up to 10 min in both cells expressing hMATE1 and expressing hMATE2-K, we set the uptake period to be 10 min in subsequent experiments to evaluate transport across the plasma membrane within the initial uptake phase. Because DAPI can emit fluorescence only after intercalation into DNA double strands, DAPI must be transported across the plasma membrane, distributed into the nucleus, and bound to DNA to be detected fluorometrically. However, because the plasma membrane is presumably the primary barrier in the whole process, the assumption here is that the fluorometrically evaluated uptake process would mainly represent transport across the plasma membrane.
Functional Characteristics of hMATEs for DAPI Transport. As shown in Fig. 4 , the specific uptakes of DAPI by hMATE1 and hMATE2-K stably expressed in MDCKII cells were both saturable, conforming to Michaelis-Menten kinetics. The K m of hMATE1 for DAPI (1.13 M) was smaller than that of hMATE2-K (3.16 M) by a factor of approximately 3, indicating that the former has a higher affinity for DAPI. Consistent K m values, 1.53 M for hMATE1 and 2.93 M for hMATE2-K, were observed for DAPI uptake for a shorter period of 1 min. This moderate difference in the affinity between the two hMATEs is within a range of differences reported by Tanihara et al. (2007) When MDCKII cells expressing hMATE2-K were permeabilized by pretreatment with 40 g/ml digitonin for 10 min and incubated with DAPI (30 M), DAPI uptake was as much as 80.1 Ϯ 5.7 FI/mg protein (n ϭ 4), being approximately 5-fold larger than the maximum uptake observed in uptake assays (Fig. 4) and, hence, indicating that the nuclear DNA of the cells has sufficient binding capacity for DAPI not to bias the evaluation of its transport. DAPI uptake (DNA binding) was found to be large enough also in permeabilized MDCKII cells expressing hMATE1 (79.9 Ϯ 6.0 FI/mg protein, n ϭ 4).
Both hMATEs were originally been identified as organic cation/H ϩ antiporters (Otsuka et al., 2005; Masuda et al., 2006) . We therefore examined the role of H ϩ in DAPI transport by them. However, as shown in Fig. 5 , the enhancements of the uptake of DAPI (0.5 M) by intracellular acidification by the NH 4 Cl prepulse method were only minimal or insignificant in both cells expressing hMATE1 and cells expressing hMATE2-K as well as in mock cells. Therefore, it is likely that both hMATEs mediate DAPI transport by a facilitative manner, without requiring a transmembrane proton gradient. Differences in DAPI uptake were also minimal or insignificant in any type of cells between the depolarized condition (K ϩ buffer) and the polarized condition (Na ϩ buffer), indicating that the membrane potential is not involved, either. However, when the extracellular pH was varied, the uptake of DAPI changed dramatically in both cells expressing hMATE1 and cells expressing hMATE2-K, whereas it remained minimal in mock cells (Fig. 6) . DAPI uptake was greatest at approximately pH 7.5 in both cells expressing hMATE1 and cells expressing hMATE2-K and decreased when pH became more acidic. Because DAPI, for which the pK a is 11.65 as estimated by the ChemAxon pK a calculator at http://www.chemaxon.com/marvin/sketch/index.jsp (Pirok et al., 2006) , is presumed to be almost completely dissociated in the entire pH range of 5.5 to 8.0, the pH-dependent change in its uptake cannot be attributed to the change in its fraction un-ionized, with an assumption that the un-ionized form is transported. Both hMATEs seem to be functionally sensitive to extracellular pH for unknown mechanism.
Effect of Various Compounds on DAPI Uptake by hMATEs. It is likely that, as indicated above, the mechanism of DAPI transport by both hMATEs is different from the H ϩ -coupled antiport mechanism for organic cations, such as cimetidine and TEA. In this section, we therefore examined whether various compounds, which inhibit organic cation/H ϩ antiport by the hMATEs, still inhibit the transport of DAPI (0.5 M) by them. As shown in Table 1 and Fig. 7 , it was found that many organic cations are effective as inhibitors of the specific uptake of DAPI by hMATE1 stably expressed in MDCKII cells and the extents of inhibition were in good correlation with those of inhibition of the specific uptake of [ 3 H]cimetidine as a typical substrate at its trace concentration of 50 nM. Specific DAPI uptake by hMATE2-K was also found to be inhibited by many organic cations with extents well correlated to those of inhibition of specific [ 3 H]cimetidine uptake.
In addition, DAPI uptake was extensively reduced in both cells expressing hMATE1 and cells expressing hMATE2-K by pretreatment with p-chloromercuribenzene sulfonate (pCMBS), a thiolmodifying reagent, and it was reversed by subsequent treatment with dithiothreitol (DTT), whereas no effect of such treatments was observed in mock cells (Fig. 8) . These results suggest the inhibition of both hMATEs by thiol modification, which is consistent with the characteristic of the organic cation/H ϩ antiport system in the kidney (Hori et al., 1987) and indicates that cysteine residues, which have a thiol group, may play an important role in the transporting function (Ohta et al., 2006; Asaka et al., 2007) .
All of these results suggest that in both hMATEs DAPI may share the substrate recognition site with organic cations, despite the difference in the mode of transporting operation. Good correlations in the extents of inhibition by various compounds between uptake assays using DAPI and [ 3 H]cimetidine as substrates indicate that DAPI can be an alternative probe substrate that enables fluorometric rapid assays of the functionality of both hMATEs.
DAPI Uptake by hOCTs and hOCTNs. We further examined whether other major organic cation transporters, hOCT1 (Zhang et al., 1998) , hOCT2 (Barendt and Wright, 2002) , hOCT3 (Kekuda et al., 1998) , hOCTN1 (Tamai et al., 1997) , and hOCTN2 (Ohashi et al., 1999) could transport DAPI, using HEK293 cells transiently expressing each of them. By fluorescent microscopic observation (Fig. 9) , DAPI was 
H]cimetidine mediated by hMATEs stably expressed in MDCKII cells
The uptakes of DAPI (0.5 M) and ͓ 3 H͔cimetidine (50 nM) were evaluated at 37°C and pH 7.4 for 10 min (DAPI) or 20 s (͓ 3 H͔cimetidine) in MDCKII cells stably expressing hMATE1, those expressing hMATE2-K, and mock cells in the presence or absence of a test compound. The specific uptakes by hMATEs are presented as means Ϯ S.E. (n ϭ 8). The control values for DAPI uptake were 2.34 and 3.70 FI/mg protein, respectively, for hMATE1 and hMATE2-K, and for cimetidine uptake were 0.75 and 0.39 pmol/mg protein, respectively.
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at ASPET Journals on October 20, 2017 dmd.aspetjournals.org taken up into HEK293 cells by transiently expressed hMATE1 and hMATE2-K, as into MDCKII cells by the stably expressed one (Fig.  2) . However, among hOCTs and hOCTNs, only hOCT1, which is mainly expressed in the liver, was found to transport DAPI (Fig. 9) . Successful expressions of all the transporters were confirmed by the increased uptakes of their typical substrates, L-[ 3 H]carnitine (10 nM) for hOCTN2 and [
14 C]TEA (10 M) for the others, in transfected cells than in mock cells (Table 2) . Because major renal organic cation transporters, hOCT2, hOCT3, hOCTN1, and hOCTN2, other than the hMATEs were thus found not to transport DAPI, the DAPI uptake assay can be a method specific to the hMATEs among organic cation transporters in the human kidney.
Discussion
DAPI is unique as a fluorescent probe in that it can emit fluorescence only when intercalated into DNA double strands (Kapuscinski, 1995) . Thus, fluorometrically evaluated DAPI uptake in the present study represents, strictly, accumulation of DNA-bound DAPI. However, assuming swift diffusional distribution of DAPI in the small intracellular space and instantaneous binding of DAPI to DNA with high capacity, the fluorometric DAPI uptake rate would represent the rate of DAPI transport across the plasma membrane. At least, the specific entry of DAPI into the cells transfected with the hMATEs, hMATE1 and hMATE2-K, is undoubtedly mediated by them and, hence, changes in fluorometric DAPI uptake is in principle attributable to those in DAPI transport by them. This finding is supported by good correlations observed for both hMATEs between the extents of inhibition of specific DAPI uptake by various compounds and those of inhibition of specific [ 3 H]cimetidine uptake (Fig. 8) . Although some deviations in correlations may indicate that we cannot exclude the possibility of the involvement of intracellular events, the uptake assay method using DAPI as a probe substrate can practically be effective for assessing the functionality of both hMATEs. Examples of its application include identification of inhibitors of these important secretory transporters with polyspecific characteristics. The fluorometric method using a plate reader is easier and faster than ordinary methods using high-performance liquid chromatography analysis and radioanalysis and can beneficially accelerate assays for, e.g., screening a large number of drugs and candidates for their potencies to inhibit the hMATEs. In addition, the irreversible DNA binding of DAPI with high capacity is also advantageous for its fluorometric detection, as it can be retained at high levels in the cells. It is also notable that DAPI enables real time visualization of its uptake process, because it does not emit fluorescence in the extracellular medium.
Even though both hMATEs were originally identified as H ϩ -coupled antiporters (Otsuka et al., 2005; Masuda et al., 2006) , the transport of DAPI by neither of them was found to be accelerated by H ϩ on the trans side. Reviewing our earlier study (Ohta et al., 2006) , we find that although TEA transport by rat MATE1 (rMATE1) was accelerated by H ϩ on the trans side, a small but significant level of TEA transport was also observed in the absence of a driving H ϩ gradient. Low levels of apparently trans H ϩ -independent TEA transport have also been reported for both hMATEs (Otsuka et al., 2005; Masuda et al., 2006) . Therefore, a possibility is that MATEs can act as facilitative transporters without H ϩ and their operations can be accelerated in the presence of countering H ϩ , depending on substrates. Trans H ϩ independence has also been observed for the transport of norfloxacin, an amphoteric compound that belongs to the fluoroquinolones, by rMATE1 in our recent study (Ohta et al., 2009) . It is also notable that norfloxacin transport by rMATE1 was dependent on extracellular pH, similar to DAPI transport by the hMATEs. Because DAPI can be transported fairly well without H ϩ by both hMATEs, the procedure of intracellular acidification, which is necessary for uptake assays using ordinary probe substrates such as cimetidine and TEA, is not required for the DAPI uptake assay. This is another merit of the assay method, which makes it easier and faster.
In conclusion, we have demonstrated that DAPI can be efficiently transported by both hMATEs, hMATE1 and hMATE2-K. By taking advantage of its fluorescent nature, it can be used as a probe substrate for rapid assays of the functionality of the hMATEs. Because the other major renal organic cation transporters were found not to transport DAPI, the DAPI uptake assay can be a method specific to the hMATEs among organic cation transporters in the human kidney.
